Key result
Autonomic blockade with atropine and propranolol did not alter the occurrence, cycle length, or number of consecutive beats of junctional tachycardia during RF ablation for AVNRT.
Why the study?
Does autonomic blockade with atropine and propranolol alter the characteristics of junctional tachycardia during radiofrequency ablation in patients with AV nodal reentrant tachycardia?
Observational (n=20)
Does autonomic blockade with atropine and propranolol alter the characteristics of junctional tachycardia during radiofrequency ablation in patients with AV nodal reentrant tachycardia?
Autonomic blockade with atropine and propranolol does not affect the genesis or characteristics of junctional tachycardia during radiofrequency ablation for AV nodal reentrant tachycardia.
Answers are grounded in this paper and cite their sources.
Autonomic blockade does not modify junctional tachycardia during AVNRT ablation; leaves open non-autonomic mechanisms in its genesis.
INTRODUCTION: The autonomic nervous system richly innervates the peri-AV nodal region and may be activated during radiofrequency (RF) ablation for AV nodal reentrant tachycardia, resulting in the generation of junctional tachycardia. The purpose of this prospective study was to determine the role of the autonomic nervous system in the genesis of junctional tachycardia. METHODS AND RESULTS: We compared the characteristics of junctional tachycardia in patients with (n = 10) and without (n = 10) autonomic blockade undergoing RF ablation for AV nodal reentrant tachycardia. Intravenous administration of atropine (0.04 mg/kg) and propranolol (0.2 mg/kg) were used to block the autonomic nervous system. There were no differences in clinical variables and baseline electrophysiologic characteristics between the two groups except for slightly longer effective refractory periods of the fast pathway and of the atrium in the autonomic blockade group. The autonomic blockade shortened the baseline sinus cycle length and effective refractory period of the ventricle only but not other electrophysiologic characteristics of the AV node. The junctional tachycardia was observed during ablation in each patient, but its occurrence and cycle length, as well as numbers of consecutive junctional beats, were not altered by the autonomic blockade. CONCLUSION: Our results indicate that the muscarinic and beta-adrenergic components of the autonomic nervous system play no role in the genesis of junctional tachycardia.
No takes yet. Share an insight, caveat, or question.
CHEN et al. (1999) conducted an observational in AV nodal reentrant tachycardia (n=20). Autonomic blockade (atropine and propranolol) vs. No autonomic blockade was evaluated on Occurrence, cycle length, and numbers of consecutive junctional beats of junctional tachycardia. Autonomic blockade with atropine and propranolol did not alter the occurrence, cycle length, or number of consecutive beats of junctional tachycardia during RF ablation for AVNRT.
Synapse has enriched 10 related papers. Consider them for comparative context: